Neura.net: Perspectives on CNS Disease Management
Member Login  |  Site Map  |  Disclaimer  |  Contact  |  Bookmark
Advanced Search
Text Size
 |  Friday, September 10, 2010 
Home
 
 
Home > Neura > Archives > Mitochondria and Oxidative Stress: Pathogenetic Mechanisms in Parkinson’s Disease > Mitochondria and Oxidative Stress: Pathogenetic Mechanisms in Parkinson’s Disease > References
References
 
1. Riess O, Krüger R, Hochstrasser H, et al. Genetic causes of Parkinson’s disease:extending the pathway. J Neural Transm Suppl. 2006;70:181-189. [PubMed]

2. Schapira AHV. Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. Lancet Neurol. 2008;7:97-109.[PubMed]

3. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson’s disease. Lancet. 1989;333:1269.[PubMed]

4. Fukae J, Mizuno Y, Hattori N. Mitochondrial dysfunction in Parkinson’s disease. Mitochondrion. 2007;7:58-62.[PubMed]

5. Tansey MG, McCoy MK, Frank-Cannon TC. Neuroinflammatory mechanisms in Parkinson’s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol. 2007;208:1-25.[PubMed]

6. Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci. 2007;120(Pt 10):1707-1716.[PubMed]

7. Goldberg MS, Fleming SM, Palacino JJ, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003;278:43628-43635.[PubMed]

8. Palacino JJ, Sagi D, Goldberg MS, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004;279: 18614-18622.[PubMed]

9. Clark IE, Dodson MW, Jiang C, et al. Drosophila Pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441:1162-1166.[PubMed]

10. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA. 2006;103:15091- 15096.[PubMed]

11. Moore DJ, Zhang L, Troncoso J, et al. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet. 2005;14:71-84.[PubMed]

12. Benmoyal-Segal L, Soreq H. Gene-environment interactions in sporadic Parkinson’s disease. J Neurochem. 2006;97:1740-1755.[PubMed]

13. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci. 2000;3:1301-1306.[PubMed]

14. Betarbet R, Canet-Aviles RM, Sherer TB, et al. Intersecting pathways to neurodegeneration in Parkinson’s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis. 2006;22:404-420.[PubMed]

15. Giasson BI, Lee VM. A new link between pesticides and Parkinson’s disease. Nat Neurosci. 2000;3:1227-1228.[PubMed]

16. Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chem Res Toxicol. 2008;21:172-188.[PubMed]

17. Gash DM, Rutland K, Hudson NL, et al. Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol. 2008;63:184-192.[PubMed]

18. Langston, JW, Ballard, P, Terud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979-980.[PubMed]

19. Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci. 2005;28:57-87.[PubMed]


   
        Add to Google Add to My Yahoo!
Neura.net is administered, managed, and populated by Expert Medical Education, a company dedicated to the education of healthcare professionals. The individual educational materials available here are supported by educational grants from Teva Neuroscience. This site is intended for U.S. audiences only. This Web site is for use by healthcare professionals only. It is not meant to serve as a substitute for a consultation with your physician. If you are a patient and would like to see Neura.net's educational material for patients, click here. Some discussions of drugs and devices contained on this Web site may include mention of uses that have not been evaluated by the United States Food and Drug Administration for safety and efficacy. Please consult complete prescribing information for any of the drugs and devices discussed before using them.
© 2010 Neura.net. All rights reserved.